Strategies for Helping Patients Navigate High...

Type 1 diabetes affects approximately 2 million people in the US and 8.4 million people worldwide. Author Desmond Schatz, MD, of the University of Florida joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence regarding diagnosis and treatment of type 1 diabe ...  Show more

Mark Cuban, entrepreneur, investor, and cofounder of the Mark Cuban Cost Plus Drug Company, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the role of pharmacy benefit managers, insurance formularies, and opaque pricing practices that shape how most ...  Show more

The power of personalized medication management — that’s the topic of Pharmacy Technology & Management Review's Maggie Lockwood's interview with Hammad Shah, R.Ph., CEO of Clarest Health. A pharmacist by trade, Hammad explains the technology-driven platform using sophistic ...

A century after its discovery, insulin remain essential in treating diabetes, and has a relatively low production cost, with a vial generally costing less than $6 to make. But those in the US pay on average 10 times more than those in other countries— leading some patients to tak ...  Show more

In this episode, we explore strategies for discontinuing benzodiazepines in hospitalized elderly patients. We discuss a recent Israeli study that tested two interventions during inpatient stays. Can a simple hospital-based intervention lead to successful long-term medi ...

Welcome to a new Hot Topics podcast from NB Medical with Dr Neal Tucker. In Just One More Thing we are joined by Dr. Jim Moore, chair of the Primary Care Cardiovascular Society, where we discuss cholesterol lowering therapies, new ways to treat heart failure, and how we may meet ...  Show more